| 标题 |
 Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet Haematology 作者：Vânia Hungria; Marek Hus; Chengcheng Fu; Vera Zherebtsova; Christopher Wård; et al 出版日期：2025-07-16 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Copyright
无情的聪健
cdercder
zzzz
蓝天
迷人的天抒
arniu2008
行走的荷尔蒙
liuzhuohao
嘻嘻哈哈
Nole
OK
ale
yjh123
雪满头
Oracle
昏睡的蟠桃
实验室
核桃
皖公网安备34019202002308
